Drug composition for NSCLC (Non Small Cell Lung Cancer) prevention and preparation method thereof

A technology for non-small cell lung cancer and a composition, applied in the field of medicine, can solve problems such as unsatisfactory use and threat to the life safety of patients

Inactive Publication Date: 2015-04-29
QINGDAO MUNICIPAL HOSPITAL
View PDF3 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is a serious threat to the life safety of patients. Although there are many drugs for the treatment of non-small cell lung cancer, their use is not satisfactory due to various reasons. Traditional Chinese medicine has rich res

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0046] Example 1:

[0047] The pharmaceutical composition for anti-non-small cell lung cancer of the present invention takes the following traditional Chinese medicine raw materials: 10 grams of Astragalus, 13 grams of Radix Ginseng, 17 grams of Ophiopogon japonicus, 20 grams of Schisandra, 21 grams of Cordyceps, 10 grams of Codonopsis, 15 grams of Chuanbei Grams, 7 grams of bitter almonds, 4 grams of loquat leaves, 13 grams of houttuynia cordata, 19 grams of angelica, 11 grams of panax notoginseng, 22 grams of velvet antler, 27 grams of leech, 18 grams of oldenlandia diffusa, 9 grams of prunella, Scutellaria barbata 15 grams, 12 grams of bezoar, 11 grams of centipede.

Example Embodiment

[0048] Example 2:

[0049] The pharmaceutical composition for anti-non-small cell lung cancer of the present invention takes the following traditional Chinese medicine raw materials: 13 grams of Astragalus, 17 grams of Radix Ginseng, 30 grams of Ophiopogon japonicus, 14 grams of Schisandra, 23 grams of Cordyceps, 6 grams of Codonopsis, 13 grams of Chuanbei Grams, 6 grams of bitter almonds, 9 grams of loquat leaves, 11 grams of houttuynia cordata, 15 grams of angelica, 8 grams of panax notoginseng, 19 grams of velvet antler, 30 grams of leech, 13 grams of oldenlandia diffusa, 5 grams of prunella, Scutellaria barbata 9 grams, 10 grams of bezoar, 12 grams of centipede.

Example Embodiment

[0050] Example 3:

[0051] The pharmaceutical composition for anti-non-small cell lung cancer of the present invention takes the following traditional Chinese medicine raw materials: 8 grams of Astragalus, 20 grams of Radix Ginseng, 19 grams of Ophiopogon japonicus, 27 grams of Schisandra, 17 grams of Cordyceps, 5 grams of Codonopsis and 19 grams of Chuanbei Grams, 10 grams of bitter almonds, 6 grams of loquat leaves, 15 grams of houttuynia cordata, 14 grams of angelica, 18 grams of panax notoginseng, 27 grams of velvet antler, 32 grams of leech, 15 grams of oldenlandia diffusa, 4 grams of prunella, Scutellaria barbata 12 grams, 8 grams of bezoar, 7 grams of centipede.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A drug composition for NSCLC (Non Small Cell Lung Cancer) prevention comprises the following raw materials: astragalus membranaceus, radix pseudostellariae, radix ophiopogonis, schisandra chinensis, cordyceps sinensis, codonopsis pilosula, bulbus fritillariae cirrhosae, semen armeniacae amarae, folium eriobotryae, houttuynia cordata, angelica sinensis, pseudo-ginseng, cornua cervi pantotrichum, leech, oldenlandia diffusa, selfheal, sculellaria barbata, calculus bovis and centipede. The drug composition achieves medication safety, has no toxic or side effects, has excellent effect, can be used for effectively solving the problem of poor treatment effect of NSCLC, improves the life quality of patients suffering from the middle and advanced stage NSCLC, and prolongs the lifetime of the patients.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to a traditional Chinese medicine composition, in particular to a non-small cell lung cancer-resistant medicinal composition and a preparation method thereof. Background technique [0002] Lung cancer is a common clinical malignant tumor. Due to the occult, invasive and metastatic nature of tumor cell growth, most patients with non-small cell lung cancer (English abbreviation: NSCLC) are in stage III or IV at the time of clinical consultation and lose the opportunity for surgery. Chemoradiation has become the main treatment. However, radiotherapy and chemotherapy have the disadvantages of damaging the normal function of the human body, uncertain curative effect, or causing excessive treatment of tumors, which affect the quality of life of patients to varying degrees. Judging from the current treatment, due to the high degree of malignancy and complex biological characteristics of lun...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8968A61P35/00A61K35/62A61K35/32A61K35/413A61K35/648
CPCA61K36/481A61K9/0095A61K9/08A61K35/32A61K35/413A61K35/62A61K35/648A61K36/068A61K36/232A61K36/258A61K36/344A61K36/36A61K36/536A61K36/539A61K36/57A61K36/73A61K36/736A61K36/748A61K36/78A61K36/79A61K36/8966A61K36/8968A61K2236/331A61K2236/39A61K2236/51A61K2236/53
Inventor 李君亢林萍张颖冯雪景
Owner QINGDAO MUNICIPAL HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap